Hussman Strategic Advisors’s AstraZeneca AZN Stock Holding History

Hussman Strategic Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,000	Closed	-$68K	–	190
2017 Q3	$68K	Hold	1,000	–	–	0.02%	178
2017 Q2	$68K	Hold	1,000	–	–	0.02%	164
2017 Q1	$62K	Hold	1,000	–	–	0.01%	180
2016 Q4	$55K	Hold	1,000	–	–	0.01%	176
2016 Q3	$66K	Hold	1,000	–	–	0.01%	154
2016 Q2	$60K	Hold	1,000	–	–	0.01%	169
2016 Q1	$56K	Hold	1,000	–	–	0.01%	176
2015 Q4	$68K	Hold	1,000	–	–	0.01%	184
2015 Q3	$64K	Sell	1,000 -41,000	-98%	-$2.7M	0.01%	197
2015 Q2	$2.68M	Sell	42,000 -10,000	-19%	-$685K	0.31%	113
2015 Q1	$3.56M	Sell	52,000 -121,500	-70%	-$8.44M	0.37%	99
2014 Q4	$12.2M	Hold	173,500	–	–	1.21%	22
2014 Q3	$12.4M	Sell	173,500 -50,000	-22%	-$3.66M	1.06%	26
2014 Q2	$16.6M	Sell	223,500 -4,500	-2%	-$325K	1.28%	19
2014 Q1	$14.8M	Buy	228,000 +200,000	+714%	+$12.9M	1.11%	36
2013 Q4	$1.66M	Sell	28,000 -40,000	-59%	-$2.17M	0.12%	124
2013 Q3	$3.53M	Sell	68,000 -307,000	-82%	-$15.4M	0.19%	114
2013 Q2	$17.7M	Buy	+375,000	New	+$19.1M	0.81%	51

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hussman Strategic Advisors's AZN Position: Q4 2017 in Review

Hussman Strategic Advisors sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 1,000 shares — an estimated $68K sold.

Hussman Strategic Advisors first reported a position in AZN in Q2 2013 and held it in 18 quarters. The position peaked at $17.7M in Q2 2013. 502 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

Hussman Strategic Advisors reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
Hussman Strategic Advisors sold 1,000 AstraZeneca shares in Q4 2017, an estimated $68K.
Hussman Strategic Advisors first reported a position in AstraZeneca in Q2 2013 and held it in 18 quarters.
Hussman Strategic Advisors's AstraZeneca position peaked at $17.7M in Q2 2013.
502 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Hussman Strategic Advisors's 13F filing for Q4 2017, filed 31 Jan 2018.